Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 17.79.
Forward PE Ratio (17.79) = Close Price ($318.04) / Consensus Forward EPS ($17.87)
FORWARD PE RATIO
17.79
SECTOR MEDIAN · HEALTHCARE
19.91
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
-10.67%
vs the sector median at left
Cencora, Inc.
Market Cap
$61.88B
Forward PE Ratio
17.79
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Cencora, Inc. (COR) | $61.88B | 17.79 |
| Moderna, Inc. (MRNA)vs › | $57.59B | N/A |
| Cardinal Health, Inc. (CAH)vs › | $53.75B | 21.30 |
| Becton, Dickinson and Company (BDX)vs › | $52.90B | 15.15 |
| Edwards Lifesciences Corporation (EW)vs › | $51.70B | 29.92 |
| Cigna Corporation (CI)vs › | $73.33B | 9.10 |
| Boston Scientific Corporation (BSX)vs › | $74.87B | 15.25 |
| Humana Inc. (HUM)vs › | $45.49B | 41.39 |
| Agilent Technologies, Inc. (A)vs › | $44.89B | 26.24 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $43.93B | 37.70 |
Trailing P/E
23.6
reported TTM EPS
Forward P/E
17.8
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $17.87 implies +32.8% EPS growth vs the reported trailing $13.46.
At today's $318.04 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-09-30 | $17.87 | $17.85 – $17.90 | 8 | 17.8x |
| 2027-09-30 | $19.80 | $19.47 – $20.12 | 7 | 16.1x |
| 2028-09-30 | $21.96 | $19.87 – $24.51 | 3 | 14.5x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
